Development of a machine learning-based multimode diagnosis system for lung cancer
Open Access
- 23 May 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (10), 9840-9854
- https://doi.org/10.18632/aging.103249
Abstract
As an emerging technology, artificial intelligence has been applied to identify various physical disorders. Here, we developed a three-layer diagnosis system for lung cancer, in which three machine learning approaches including decision tree C5.0, artificial neural network (ANN) and support vector machine (SVM) were involved. The area under the curve (AUC) was employed to evaluate their decision powers. In the first layer, the AUCs of C5.0, ANN and SVM were 0.676, 0.736 and 0.640, ANN was better than C5.0 and SVM. In the second layer, ANN was similar with SVM but superior to C5.0 supported by the AUCs of 0.804, 0.889 and 0.825. Much higher AUCs of 0.908, 0.910 and 0.849 were identified in the third layer, where the highest sensitivity of 94.12% was found in C5.0. These data proposed a three-layer diagnosis system for lung cancer: ANN was used as a broad-spectrum screening subsystem basing on 14 epidemiological data and clinical symptoms, which was firstly adopted to screen high-risk groups; then, combining with additional 5 tumor biomarkers, ANN was used as an auxiliary diagnosis subsystem to determine the suspected lung cancer patients; C5.0 was finally employed to confirm lung cancer patients basing on 22 CT nodule-based radiomic features.Keywords
This publication has 37 references indexed in Scilit:
- Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trialThorax, 2016
- Assessment of a Combined Panel of Six Serum Tumor Markers for Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Machine learning applications in cancer prognosis and predictionComputational and Structural Biotechnology Journal, 2015
- Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancersThe Lancet Oncology, 2014
- Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force RecommendationAnnals of Internal Medicine, 2013
- The Effect of Artificial Neural Network Model Combined with Six Tumor Markers in Auxiliary Diagnosis of Lung CancerJournal of Medical Systems, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: A single center analysisCancer Biology & Therapy, 2011
- UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancerThorax, 2011
- Uniqueness of medical data miningArtificial Intelligence in Medicine, 2002